🇺🇸 FDA
Patent

US 11247969

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61KA61K31/4545A61K45/06

Quick answer

US patent 11247969 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623